Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility
David T Nash1, Michael S McNamara21Syracuse Preventive Cardiology, Syracuse, New York, USA; 2Oxford PharmaGenesis Inc., Newtown, Pennsylvania, USAAbstract: The morbidity and mortality benefits of lowering blood pressure (BP) in hypertensive patients are well established, with most individuals requir...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-10-01
|
Series: | Integrated Blood Pressure Control |
Online Access: | http://www.dovepress.com/valsartan-combination-therapy-in-the-management-of-hypertension-ndash--a3667 |